I see everyone is excited about the upcoming June liver

New Post Public Reply Private Reply Replies (2) Message Board
Respert24
1,029
I see everyone is excited about the upcoming June liver conference where topline Nash results for Leronlimab are slated to be discussed. It's undoubtably a good thing. But if I may shed a little light on what looks to be happening at the conference, I think it could strengthen my theory that we won't have to wait until then to get the topline report.

I've attended many medical conferences in my time as a combination medical sales rep/Adonis, and they're all structured similarly. Learn about the conference's topics at your choice of sessions, earning continuing education credits along the way. Many courses overlap, causing the attendees to choose which ones to miss and which ones to attend. A lot of the attendees have very specific reasons for going. It might be cancer, or Nash, or just to complete their continuing education requirements in a fun city amongst friends/colleagues. There are marquee events each day, set up in the main (best) conference room and given heavy focus by the organizers. Attendees will have much of their conference taken up by marquee events, as well as the singled out sessions or tracts they decide to focus on. And then there are the poster session, which is what Cytodyn’s “session” is listed as.

These poster sessions are usually a time in which they give students and researchers a chance to show off what they've been working on. It’s kind of like overflow for everything that deserves to be there but that there isn’t enough time or space to fit into the main program. And it's pretty much exactly what it sounds like, a session where there are a bunch of posters spread about, detailing studies or research conducted. One poster per topic, which needs to detail all the key points plus the conclusion. Those who did the work are usually standing there to explain the results and answer any questions. But the key here is that this is usually done at the end of a day, or during breaks. In other words, while it's always a part of conferences like this, it isn't always a focus. Like I said, it’s sort of an overflow thing.

And if you think about how boring a full day of back to back to back sessions are, if you're "lucky" enough to have ever had to go to a long conference, you'll know that when things aren't mandatory people tend to use those times for themselves. They go back to the room to drop a homecourt deuce, they call the family, they go find a bite to eat and refill the coffee. Statistically, some of them will masturbate. It’s science.

This isn't to say that this poster session won't have plenty of people wandering by to hear or see the results. It just means that in the grand scheme of conference related things, it's not going to be a priority or even a built-in part of the standard attendee itinerary. And for that reason, I can't imagine that Cytodyn's brain trust thinks that would be a good way to debut the topline 700mg Nash data to the world.

Which means by the time the conference comes around they'll have already announced it. Hell, maybe even this morning. Though I arbitrarily picked May 24th as the day it’ll come because fool me once, shame on you. Fool me twice, shame on me. Fool me 42 times? Now I pick random dates and don’t believe anything until I see it. I ain’t nobody’s fool!

Which made me think of the song lyrics “just a fool to believe…she’s like the wind”, so I googled it to be sure I had the lyrics correct in case I wanted to make a joke about it. Now I’m today years old just learning that Patrick Swayze sung the damn thing. I have no joke now. Too stunned.

Anyway, look out for topline results before the June conference. I’d bet the life of today’s greatest living actor/singer, Patrick Swayze, on it.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 144

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Lotte's Songdo Plant 1 Puts 120,000 Liters on Deck

Updated Category News Views 95

A 120,000-liter biomanufacturing plant is not a ribbon-cutting trinket; it is a serious industrial bet that has to earn its keep one qualified batch at a time. LOTTE Biologics has completed Plant 1 at its Songdo Bio Campus in Incheon, South Korea, giving the company a sizable new production base as it tries to become a more consequential player in the global CDMO...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 239

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Parents Hand Kids Devices Years Before They Intended

Updated Category News Views 286

A nine-year-old with a smartphone used to raise eyebrows; this survey says it is increasingly the household baseline. All About Cookies, working with parental-control company Bark, surveyed U.S. parents and found that children typically receive personal devices well before their parents believe they should. That mismatch is not some cute little parenting contradiction. It...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 73

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight

Updated Category News Views 121

A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 90

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 96

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
FP Markets Puts Anthropic CFD Into the AI Trading Mix

Updated Category News Views 28

A fresh AI bellwether is about to meet the CFD crowd. FP Markets says it will add an Anthropic share CFD, identified as ANT.xnas, to its lineup on November 19, 2026. Clients worldwide are slated to access it through MetaTrader 5, cTrader, and TradingView. That is a tidy distribution expansion, but it lands with the usual AI-market fireworks already hissing in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Trifork Group Launches 2025 Share-Based Incentive Program

Updated Category News Views 333

Trifork's Innovative Share-Based Incentive Program The Trifork Group AG has taken a significant step towards enhancing employee satisfaction and retention with the introduction of its Share-Based Incentive Program for 2025. This strategic decision supports Trifork’s ongoing commitment to fostering a motivated workforce and aligns with the company’s vision for growth...

Continue Reading
China's Agricultural Modernization: Dezhou's Vital Role

Updated Category News Views 40

Modern Farming Revolution in Dezhou Fifteen years ago, farming technology in Dezhou was a distant dream; today, it's a shining reality. Picture this: Song Zhijie, a veteran farmer, reflecting on a dusty 1997 summer harvest. Now, he sits in air-conditioned cabins, operating state-of-the-art machinery, basking in the efficiency that modern technology has granted. Dezhou, a...

Continue Reading
Exploring the Growth of the Cultured Wheat Market: 2024-2034

Updated Category News Views 142

Exploring the Growth of the Cultured Wheat Market The cultured wheat market is set for remarkable growth, with projections indicating an increase from USD 704.1 million in 2024 to USD 1,273.0 million by 2034. This growth translates to a solid compound annual growth rate (CAGR) of 6.1% over the decade. The rising demand for cultured wheat is driven by several factors,...

Continue Reading
Transforming Urban Mobility: Hikvision's AIoT Innovations

Updated Category News Views 292

Hikvision showcased its game-changing AIoT innovations at the ITS World Congress, zeroing in on making urban mobility safer, smarter, and greener. Their booth was abuzz with tech that’s not just flashy; it’s a serious play aimed at reshaping how we think about transport. The emphasis here? A commitment to road safety that's palpable, with cutting-edge solutions that...

Continue Reading
Avem Health Partners Welcomes Military Veterans to Board of Directors

Updated Category News Views 90

Enhancing Leadership at Avem Health Partners Avem Health Partners, a well-respected hospital management company based in Oklahoma City, is excited to announce the recent appointments of Keith Walker and Barbara Holcomb to its Board of Directors. This strategic decision aims to infuse the organization with a wealth of experience from both military and corporate...

Continue Reading